KBI Biopharma vs Richter BioLogics: CDMO Comparison
How does KBI Biopharma compare to Richter BioLogics?
As of Nov 2026, KBI Biopharma: 2 FDA inspections (including 0 NAI, 2 VAI and 0 OAI), 1 EMA/MHRA GMP certificate. Signal Score 84.1. Richter BioLogics: no FDA inspections on file, 9 EMA/MHRA GMP certificates. Signal Score 82.9. Counts are the established FDA, EMA and MHRA records on each profile. CDMOs cannot pay to change a score.
Side-by-side comparison of KBI Biopharma and Richter BioLogics on independent FDA inspections, EMA and MHRA GMP certificates, clinical-program activity, and CDMO Signal Score. Data sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.
Key differences
- KBI Biopharma has FDA inspections on record (2); Richter BioLogics does not yet appear in the FDA inspection database.
- Both maintain clean enforcement records — no FDA OAI classifications or warning letters on file for either CDMO.
- Richter BioLogics holds 9 active EMA GMP certificates; KBI Biopharma does not appear in EudraGMDP.
- KBI Biopharma maintains 1 MHRA / UK GMP certificate; Richter BioLogics does not.
Across the cross-modality scorecard, KBI Biopharma carries the higher composite Signal Score — but the right choice depends on the specific modality, phase, and geography of the program.
Frequently asked: KBI Biopharma vs Richter BioLogics
How does KBI Biopharma compare to Richter BioLogics?
On CDMO Signal's composite Signal Score, KBI Biopharma is 84/100 and Richter BioLogics is 83/100; KBI Biopharma has 2 FDA inspections on record vs 0 for Richter BioLogics; European coverage is 1 active EMA+MHRA certificate for KBI Biopharma vs 9 for Richter BioLogics. Both are tracked in the CDMO Signal directory. The scorecard above breaks down every metric side by side — use it alongside each CDMO's individual profile for the full regulatory and clinical footprint.
Which has the stronger FDA inspection record, KBI Biopharma or Richter BioLogics?
Both KBI Biopharma and Richter BioLogics maintain clean enforcement records on file — no FDA warning letters and no OAI classifications. KBI Biopharma has 2 FDA inspections on record; Richter BioLogics has 0.
How do KBI Biopharma and Richter BioLogics compare on European GMP coverage?
KBI Biopharma holds 0 active EMA GMP certificates and 1 MHRA / UK certificate. Richter BioLogics holds 9 active EMA GMP certificates and 0 MHRA / UK certificates. Use these counts as a proxy for the breadth of each CDMO's European regulatory footprint.
What does the Signal Score gap mean in practice?
KBI Biopharma carries a Signal Score of 84/100 and Richter BioLogics carries 83/100 — essentially tied for KBI Biopharma. The Signal Score combines quality (FDA inspections + EMA/MHRA GMP), operational performance, financial stability, and capacity intelligence. CDMOs cannot pay to influence their score.
Use the free AI matchmaker to weigh both against your specific requirements — capacity, modality, regulatory record, geography — and surface other qualified options.
Find & compare CDMOs →